- call +1-201-465-4211
- email sales@mrinsights.biz
Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.
Scope of the Report:
The classification of Transdermal Drug Delivery System includes Fentanyl, Nitroglycerin, Estradiol, Nicotine and Other, and the revenue proportion of Fentanyl in 2016 is about 31.1%. Transdermal Drug Delivery System can be used for OTC, Rx. The most proportion of Transdermal Drug Delivery System is OTC, and the sales proportion is about 83.3% in 2016.
North America is the largest sales place, with a revenue market share nearly 41% in 2016. Following North America, Europe is the second largest sales place with the revenue market share of 28%. China and Japan are also important sales regions for Transdermal Drug Delivery System.
The unprecedented global shift in the adoption of unhealthy lifestyles is to be responsible for the high prevalence of chronic diseases, such as cancer and diabetes, which is expected to drive the clinical urgency to incorporate transdermal drug delivery systems in the future treatments. Moreover, the rising geriatric population base, which is highly susceptible to developing the aforementioned chronic diseases are expected to propel the demand for highly efficacious pharmacological drugs.
Market competition is intense. Hisamitsu, Mylan, Johnson & Johnson, Actavis, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The global Transdermal Drug Delivery System market is valued at 8950 million USD in 2018 and is expected to reach 19000 million USD by the end of 2024, growing at a CAGR of 13.4% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Transdermal Drug Delivery System.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Transdermal Drug Delivery System market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Transdermal Drug Delivery System market by product type and applications/end industries.
Market Segment by Companies, this report covers
Hisamitsu
Mylan
GSK
Novartis
Teve (Actavis)
Johnson & Johnson
Lohmann
Teikoku Seiyaku
Bayer
Lingrui
Sanofi
Qizheng
Endo
Huarun 999
Haw Par
Nichiban
Mentholatum Company
Laboratoires Genevrier
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Fentanyl
Nitroglycerin
Estradiol
Nicotine
Other
Market Segment by Applications, can be divided into
OTC
Rx
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Transdermal Drug Delivery System Market Overview
1.1 Product Overview and Scope of Transdermal Drug Delivery System
1.2 Classification of Transdermal Drug Delivery System by Types
1.2.1 Global Transdermal Drug Delivery System Revenue Comparison by Types (2019-2024)
1.2.2 Global Transdermal Drug Delivery System Revenue Market Share by Types in 2018
1.2.3 Fentanyl
1.2.4 Nitroglycerin
1.2.5 Estradiol
1.2.6 Nicotine
1.2.7 Other
1.3 Global Transdermal Drug Delivery System Market by Application
1.3.1 Global Transdermal Drug Delivery System Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 OTC
1.3.3 Rx
1.4 Global Transdermal Drug Delivery System Market by Regions
1.4.1 Global Transdermal Drug Delivery System Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Transdermal Drug Delivery System Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Transdermal Drug Delivery System Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Transdermal Drug Delivery System Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Transdermal Drug Delivery System Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Transdermal Drug Delivery System Status and Prospect (2014-2024)
1.5 Global Market Size of Transdermal Drug Delivery System (2014-2024)
2 Manufacturers Profiles
2.1 Hisamitsu
2.1.1 Business Overview
2.1.2 Transdermal Drug Delivery System Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Hisamitsu Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2017-2018)
2.2 Mylan
2.2.1 Business Overview
2.2.2 Transdermal Drug Delivery System Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Mylan Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2017-2018)
2.3 GSK
2.3.1 Business Overview
2.3.2 Transdermal Drug Delivery System Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 GSK Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2017-2018)
2.4 Novartis
2.4.1 Business Overview
2.4.2 Transdermal Drug Delivery System Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Novartis Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2017-2018)
2.5 Teve (Actavis)
2.5.1 Business Overview
2.5.2 Transdermal Drug Delivery System Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Teve (Actavis) Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2017-2018)
2.6 Johnson & Johnson
2.6.1 Business Overview
2.6.2 Transdermal Drug Delivery System Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Johnson & Johnson Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2017-2018)
2.7 Lohmann
2.7.1 Business Overview
2.7.2 Transdermal Drug Delivery System Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Lohmann Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2017-2018)
2.8 Teikoku Seiyaku
2.8.1 Business Overview
2.8.2 Transdermal Drug Delivery System Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Teikoku Seiyaku Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2017-2018)
2.9 Bayer
2.9.1 Business Overview
2.9.2 Transdermal Drug Delivery System Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Bayer Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2017-2018)
2.10 Lingrui
2.10.1 Business Overview
2.10.2 Transdermal Drug Delivery System Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Lingrui Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2017-2018)
2.11 Sanofi
2.11.1 Business Overview
2.11.2 Transdermal Drug Delivery System Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Sanofi Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2017-2018)
2.12 Qizheng
2.12.1 Business Overview
2.12.2 Transdermal Drug Delivery System Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Qizheng Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2017-2018)
2.13 Endo
2.13.1 Business Overview
2.13.2 Transdermal Drug Delivery System Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Endo Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2017-2018)
2.14 Huarun 999
2.14.1 Business Overview
2.14.2 Transdermal Drug Delivery System Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Huarun 999 Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2017-2018)
2.15 Haw Par
2.15.1 Business Overview
2.15.2 Transdermal Drug Delivery System Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Haw Par Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2017-2018)
2.16 Nichiban
2.16.1 Business Overview
2.16.2 Transdermal Drug Delivery System Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Nichiban Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2017-2018)
2.17 Mentholatum Company
2.17.1 Business Overview
2.17.2 Transdermal Drug Delivery System Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Mentholatum Company Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2017-2018)
2.18 Laboratoires Genevrier
2.18.1 Business Overview
2.18.2 Transdermal Drug Delivery System Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Laboratoires Genevrier Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2017-2018)
3 Global Transdermal Drug Delivery System Market Competition, by Players
3.1 Global Transdermal Drug Delivery System Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Transdermal Drug Delivery System Players Market Share
3.2.2 Top 10 Transdermal Drug Delivery System Players Market Share
3.3 Market Competition Trend
4 Global Transdermal Drug Delivery System Market Size by Regions
4.1 Global Transdermal Drug Delivery System Revenue and Market Share by Regions
4.2 North America Transdermal Drug Delivery System Revenue and Growth Rate (2014-2019)
4.3 Europe Transdermal Drug Delivery System Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Transdermal Drug Delivery System Revenue and Growth Rate (2014-2019)
4.5 South America Transdermal Drug Delivery System Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Transdermal Drug Delivery System Revenue and Growth Rate (2014-2019)
5 North America Transdermal Drug Delivery System Revenue by Countries
5.1 North America Transdermal Drug Delivery System Revenue by Countries (2014-2019)
5.2 USA Transdermal Drug Delivery System Revenue and Growth Rate (2014-2019)
5.3 Canada Transdermal Drug Delivery System Revenue and Growth Rate (2014-2019)
5.4 Mexico Transdermal Drug Delivery System Revenue and Growth Rate (2014-2019)
6 Europe Transdermal Drug Delivery System Revenue by Countries
6.1 Europe Transdermal Drug Delivery System Revenue by Countries (2014-2019)
6.2 Germany Transdermal Drug Delivery System Revenue and Growth Rate (2014-2019)
6.3 UK Transdermal Drug Delivery System Revenue and Growth Rate (2014-2019)
6.4 France Transdermal Drug Delivery System Revenue and Growth Rate (2014-2019)
6.5 Russia Transdermal Drug Delivery System Revenue and Growth Rate (2014-2019)
6.6 Italy Transdermal Drug Delivery System Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Transdermal Drug Delivery System Revenue by Countries
7.1 Asia-Pacific Transdermal Drug Delivery System Revenue by Countries (2014-2019)
7.2 China Transdermal Drug Delivery System Revenue and Growth Rate (2014-2019)
7.3 Japan Transdermal Drug Delivery System Revenue and Growth Rate (2014-2019)
7.4 Korea Transdermal Drug Delivery System Revenue and Growth Rate (2014-2019)
7.5 India Transdermal Drug Delivery System Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Transdermal Drug Delivery System Revenue and Growth Rate (2014-2019)
8 South America Transdermal Drug Delivery System Revenue by Countries
8.1 South America Transdermal Drug Delivery System Revenue by Countries (2014-2019)
8.2 Brazil Transdermal Drug Delivery System Revenue and Growth Rate (2014-2019)
8.3 Argentina Transdermal Drug Delivery System Revenue and Growth Rate (2014-2019)
8.4 Colombia Transdermal Drug Delivery System Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Transdermal Drug Delivery System by Countries
9.1 Middle East and Africa Transdermal Drug Delivery System Revenue by Countries (2014-2019)
9.2 Saudi Arabia Transdermal Drug Delivery System Revenue and Growth Rate (2014-2019)
9.3 UAE Transdermal Drug Delivery System Revenue and Growth Rate (2014-2019)
9.4 Egypt Transdermal Drug Delivery System Revenue and Growth Rate (2014-2019)
9.5 Nigeria Transdermal Drug Delivery System Revenue and Growth Rate (2014-2019)
9.6 South Africa Transdermal Drug Delivery System Revenue and Growth Rate (2014-2019)
10 Global Transdermal Drug Delivery System Market Segment by Type
10.1 Global Transdermal Drug Delivery System Revenue and Market Share by Type (2014-2019)
10.2 Global Transdermal Drug Delivery System Market Forecast by Type (2019-2024)
10.3 Fentanyl Revenue Growth Rate (2014-2024)
10.4 Nitroglycerin Revenue Growth Rate (2014-2024)
10.5 Estradiol Revenue Growth Rate (2014-2024)
10.6 Nicotine Revenue Growth Rate (2014-2024)
10.7 Other Revenue Growth Rate (2014-2024)
11 Global Transdermal Drug Delivery System Market Segment by Application
11.1 Global Transdermal Drug Delivery System Revenue Market Share by Application (2014-2019)
11.2 Transdermal Drug Delivery System Market Forecast by Application (2019-2024)
11.3 OTC Revenue Growth (2014-2019)
11.4 Rx Revenue Growth (2014-2019)
12 Global Transdermal Drug Delivery System Market Size Forecast (2019-2024)
12.1 Global Transdermal Drug Delivery System Market Size Forecast (2019-2024)
12.2 Global Transdermal Drug Delivery System Market Forecast by Regions (2019-2024)
12.3 North America Transdermal Drug Delivery System Revenue Market Forecast (2019-2024)
12.4 Europe Transdermal Drug Delivery System Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Transdermal Drug Delivery System Revenue Market Forecast (2019-2024)
12.6 South America Transdermal Drug Delivery System Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Transdermal Drug Delivery System Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Transdermal Drug Delivery System Picture
Table Product Specifications of Transdermal Drug Delivery System
Table Global Transdermal Drug Delivery System and Revenue (
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
